Am J Kidney Dis

1. BU L, Lee JH, Quigley MM, Elahimehr R, et al
   IgG3kappa Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.
   Am J Kidney Dis. 2025 Sep 18:S0272-6386(25)01024.
   

   >> Share

   
   

   
   Ann Neurol

2. SIAVOSHI F, Smith MD, Cassard S, Moreau GB, et al
   Fasting Mimicking Diets Reverse Accelerated Biological Aging in Multiple Sclerosis.
   Ann Neurol. 2025 Sep 19. doi: 10.1002/ana.78044.
   

   >> Share

   
   

   
   Brain

3. FURLAN R, Schaedelin S, Frederiksen JL, Watanabe M, et al
   Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.
   Brain. 2025 Sep 24:awaf345. doi: 10.1093.
   

   >> Share

   
   

   
   Diabetes

4. ZHOU X, Iakovliev A, McGurnaghan S, Erabadda B, et al
   Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.
   Diabetes. 2025 Aug 11:db250067. doi: 10.2337/db25-0067.
   

   >> Share

   
   
5. EVANS-MOLINA C, Dor Y, Lernmark A, Mathieu C, et al
   The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
   Diabetes. 2025 Jul 30:dbi250011. doi: 10.2337/dbi25-0011.
   

   >> Share

   
   

   
   J Autoimmun

6. LIU X, Wang C, Guan X
   Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus.
   J Autoimmun. 2025;157:103488.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

7. GERA S, Rearson A, Baker G, Douvas JL, et al
   Changes in 90-Day Time in Range Among Youth with Type 1 Diabetes Initiating Different Automated Insulin Delivery Systems.
   J Clin Endocrinol Metab. 2025 Jan 15:dgaf006. doi: 10.1210.
   

   >> Share

   
   
8. JAHOOR F, Hsu JW, Keene KR, Peacock WF, et al
   Amino acids and CART distinguish A-beta+ Ketosis-Prone Diabetes from type 1 and type 2 diabetes during hyperglycemic crises.
   J Clin Endocrinol Metab. 2025 Jan 16:dgaf033. doi: 10.1210.
   

   >> Share

   
   
9. ABU IRSHEED G, Steffen A, Martyn-Nemeth P, Park M, et al
   Multidimensional Sleep Health, Glycemic Control, and Self-Reported Outcomes in Type 1 Diabetes: A Cross-Sectional Study.
   J Clin Endocrinol Metab. 2025 Jan 16:dgaf032. doi: 10.1210.
   

   >> Share

   
   
10. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls.
    J Clin Endocrinol Metab. 2025 Jan 20:dgaf030. doi: 10.1210.
    

    >> Share

    
    
11. CAMOIN M, Mohammedi K, Saulnier PJ, Hadjadj S, et al
    Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population.
    J Clin Endocrinol Metab. 2025 Feb 4:dgae852. doi: 10.1210.
    

    >> Share

    
    

    
    J Neuroimmunol

12. MARTINEZ-MEDINA S, Olivas-Dominguez ER, Romero-Armenta RN, Avalos-Arias A, et al
    PERM associated with thymic carcinoma with triple-autoantibody positivity: case report and literature review.
    J Neuroimmunol. 2025;409:578753.
    

    >> Share

    
    

    
    J Neurol

13. ROMANO F, Rocca MA, Pagani E, Amato MP, et al
    Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trial.
    J Neurol. 2025;272:645.
    

    >> Share

    
    
14. MORENO-NAVARRO L, Mora-Diaz S, Ruiz-Escribano-Menchen L, Sempere AP, et al
    Kappa free light chain index as a diagnostic and prognostic biomarker in multiple sclerosis.
    J Neurol. 2025;272:646.
    

    >> Share

    
    
15. HABEK M, Adamec I, Gabelic T, Barun B, et al
    Diagnostic performance of the 2010, 2017, and 2024 McDonald criteria: clinical implications in multiple sclerosis.
    J Neurol. 2025;272:637.
    

    >> Share

    
    

    
    J Pediatr Endocrinol Metab

16. NENEMAN J, Niedziela M, Dyrka K, Banaszak-Ziemska M, et al
    Endocrinopathies associated with pediatric common variable immunodeficiency.
    J Pediatr Endocrinol Metab. 2025;38:946-955.
    

    >> Share

    
    

    
    Kidney Int

17. FLOEGE J, Barratt J, Cook HT, Noronha IL, et al
    Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
    Kidney Int. 2025;108:548-554.
    

    >> Share

    
    
18. THEIS JD, Nasr SH, Sethi S
    Absence of PCDH7-associated dual antigens in membranous nephropathy.
    Kidney Int. 2025;108:707-708.
    

    >> Share

    
    

    
    Lancet Neurol

19. GALETTA SL, Bennett JL
    Shedding new light on the diagnosis of multiple sclerosis.
    Lancet Neurol. 2025;24:807-808.
    

    >> Share

    
    
20. FOX RJ, Jones SE
    Translating MRI advances into multiple sclerosis diagnosis: bridging science and clinical practice.
    Lancet Neurol. 2025;24:808-810.
    

    >> Share

    
    
21. MONTALBAN X, Lebrun-Frenay C, Oh J, Arrambide G, et al
    Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.
    Lancet Neurol. 2025;24:850-865.
    

    >> Share

    
    
22. BARKHOF F, Reich DS, Oh J, Rocca MA, et al
    2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis.
    Lancet Neurol. 2025;24:866-879.
    

    >> Share

    
    
23. SAIDHA S, Green AJ, Leocani L, Vidal-Jordana A, et al
    The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis.
    Lancet Neurol. 2025;24:880-892.
    

    >> Share

    
    

    
    Mult Scler

24. UYSAL TAN F, Tan MO
    Comment on 'short- and mid-term efficacy of sacral neuromodulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis'.
    Mult Scler. 2025 Sep 22:13524585251380003. doi: 10.1177/13524585251380003.
    

    >> Share

    
    
25. CAROLUS B, Dequirez PL, Olivier L, Hafez S, et al
    Response to the letter by Uysal Tan and Tan regarding our article "short- and mid-term efficacy of sacral neuromodulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis".
    Mult Scler. 2025 Sep 22:13524585251380411. doi: 10.1177/13524585251380411.
    

    >> Share

    
    
26. SHIPLEY J, Beadnall HN, Sanfilippo PG, Horakova D, et al
    Disease course after pregnancy in women with progressive multiple sclerosis symptoms.
    Mult Scler. 2025 Sep 20:13524585251368248. doi: 10.1177/13524585251368248.
    

    >> Share

    
    
27. SALAZAR-CAMELO A, Vega L, Fadlallah Y, Bou Rjeily N, et al
    Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.
    Mult Scler. 2025 Sep 19:13524585251375350. doi: 10.1177/13524585251375350.
    

    >> Share

    
    

    
    Neurol Clin Pract

28. LI P, Lin JK, Klebanoff MJ, Palkar R, et al
    Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis.
    Neurol Clin Pract. 2025;15:e200536.
    

    >> Share

    
    

    
    Neurology

29. PORTACCIO E, Betti M, De Meo E, Pasto L, et al
    Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.
    Neurology. 2025;105:e213977.
    

    >> Share

    
    
30. O'NEILL KA, Charvet L, Waltz M, George A, et al
    Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years.
    Neurology. 2025;105:e214142.
    

    >> Share

    
    
31. OLIVIERI E, Muller J, Toosy AT
    Predicting Disability Using PIRA in Multiple Sclerosis: Is It as Straightforward as It Appears?
    Neurology. 2025;105:e214206.
    

    >> Share

    
    
32. PORTACCIO E, Amato MP
    Moving Closer to the Prevention of Cognitive Disability in People With Pediatric-Onset Multiple Sclerosis.
    Neurology. 2025;105:e214244.
    

    >> Share

    
    

    
    PLoS One

33. LI L, Olcer M, Wang Z, Song Y, et al
    IFN-beta therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses.
    PLoS One. 2025;20:e0330867.
    

    >> Share

    
    

    
    Thyroid

34. POLKAMPALLY S, Halagur AS, Green A, Wei E, et al
    Incidence of Pediatric Graves' Disease in the United States: An Epidemiological Analysis of 2007-2022 Outpatient Insurance Claims.
    Thyroid. 2025 Sep 22. doi: 10.1177/10507256251382559.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share